Malaysian Genomics Resource Market Cap ($11.94 Million)
Market Cap & Net Worth: Malaysian Genomics Resource (0155)
Malaysian Genomics Resource market cap. Malaysian Genomics Resource (KLSE:0155) has a market capitalization of $11.94 Million (RM47.54 Million) as of November 1, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #26493 globally and #796 in its home market, demonstrating a -5.97% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Malaysian Genomics Resource's stock price RM0.32 by its total outstanding shares 150931480 (150.93 Million). Also see cash efficiency ratio of Malaysian Genomics Resource for how efficiently the company converts equity into cash flow.
Malaysian Genomics Resource Market Cap History (2015–2026)
Malaysian Genomics Resource market cap history from 2015 to 2026. Data shows change from $28.42 Million to $11.94 Million (-5.00% CAGR). Check 0155 share price today for real-time trading data and today's change.
Malaysian Genomics Resource Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Malaysian Genomics Resource's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Malaysian Genomics Resource net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.49x
Malaysian Genomics Resource's market cap is 1.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $13.26 Million | $9.87 Million | $589.30K | 1.34x | 22.51x |
| 2018 | $8.91 Million | $26.16 Million | -$4.53 Million | 0.34x | N/A |
| 2019 | $15.35 Million | $283.06K | -$3.84 Million | 54.22x | N/A |
| 2020 | $38.65 Million | $951.35K | $17.10 Million | 40.63x | 2.26x |
| 2021 | $43.96 Million | $1.78 Million | -$4.29 Million | 24.65x | N/A |
| 2022 | $28.99 Million | $28.36 Million | $7.21 Million | 1.02x | 4.02x |
| 2023 | $16.86 Million | $8.36 Million | -$14.25 Million | 2.02x | N/A |
| 2024 | $13.07 Million | $12.86 Million | -$21.51 Million | 1.02x | N/A |
| 2025 | $9.09 Million | $5.52 Million | -$4.19 Million | 1.65x | N/A |
| 2026 | $11.94 Million | $8.02 Million | -$2.38 Million | 1.49x | N/A |
Competitor Companies of 0155 by Market Capitalization
Companies near Malaysian Genomics Resource in the global market cap rankings as of November 1, 2026. Also see balance sheet size of Malaysian Genomics Resource for a full breakdown of the balance sheet.
Key companies related to Malaysian Genomics Resource by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #143 globally with a market cap of $164.04 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #480 globally with a market cap of $56.33 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #530 globally with a market cap of $51.40 Billion USD ( CN¥351.23 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $697.00 |
| #143 | Danaher Corporation | NYSE:DHR | $164.04 Billion | $232.23 |
| #480 | Natera Inc | NASDAQ:NTRA | $56.33 Billion | $414.30 |
| #530 | WuXi AppTec Co Ltd | SHG:603259 | $51.40 Billion | CN¥142.01 |
Market Capitalization of Malaysian Genomics Resource (2015–2026)
Market capitalization of Malaysian Genomics Resource from 2015 to today. Between 2015 and today, Malaysian Genomics Resource's market cap moved from $28.42 Million to $ 11.94 Million, with a yearly change of -5.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM11.94 Million | +31.25% |
| 2025 | RM9.09 Million | -30.43% |
| 2024 | RM13.07 Million | -22.47% |
| 2023 | RM16.86 Million | -41.83% |
| 2022 | RM28.99 Million | -34.05% |
| 2021 | RM43.96 Million | +13.73% |
| 2020 | RM38.65 Million | +151.85% |
| 2019 | RM15.35 Million | +72.34% |
| 2018 | RM8.91 Million | -32.86% |
| 2017 | RM13.26 Million | -36.36% |
| 2016 | RM20.84 Million | -26.67% |
| 2015 | RM28.42 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Malaysian Genomics Resource was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $11.94 Million USD |
| MoneyControl | $11.94 Million USD |
| MarketWatch | $11.94 Million USD |
| marketcap.company | $11.94 Million USD |
| Reuters | $11.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Malaysian Genomics Resource
Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services in Malaysia. The company offers genetic screening services that includes Dtect and Origene genetic testing solutions which provides individuals with insights into genetic predispositions related to health risks, wellness, and lifestyle traits. It al… Read more